ROLE OF SUBSTRATE LIPOPHILICITY ON THE N-DEMETHYLATION AND TYPE-I BINDING OF 3-O-ALKYLMORPHINE ANALOGS
ROLE OF SUBSTRATE LIPOPHILICITY ON THE N-DEMETHYLATION AND TYPE-I BINDING OF 3-O-ALKYLMORPHINE ANALOGS
复制标题
DOI:
10.1021/jm00364a002
复制
发表时间:
1983-01-01
影响因子:
7.3
通讯作者:
HOLTZMAN, JL
中科院分区:
文献类型:
--
作者:
DUQUETTE, PH;ERICKSON, RR;HOLTZMAN, JL
A series of 3-O-alkylmorphine analogs [codeine, 3-O-ethyl-, 3-O-butyl-, 3-O-propyl-, 3-O-pentyl-, 3-O-hexyl-, 3-O-heptyl-, 3-O-octyl-, 3-O-nonyl-, 3-O-decyl- and 3-O-dodecylmorphine] was synthesized to determine if there was a good correlation between the rate of metabolism, type I binding affinity and lipid solubility. The Km for the N-demethylation declines with increasing chain length from C1 to C9, while for increasing chain length the Vmax for the N-demethylation increases to a maximum of 15.20 nmol/min per (mg of protein) for the butyl analog (C4) and then slowly declines with analogs with chain lengths greater than butyl (C4). The decyl (C10)and dodecyl (C12) analogs showed no activity. There was a good correlation between the lipophilicity and Km values, except for codeine and the C10 and C12 analogs. The type I binding dissociation constants (K8) also decreased with increasing alkyl chain length width an excellent correlation between the Ks and log P. The ODmax [maximum O-dealkylation rate] did not change with increasing the chain length of the analogs. Apparently, in male rat hepatic microsomes the catalytic site for N-demethylation and the site for type I binding in this series of compounds are similar but distinct.